* C1 corrector GLPG2222 for cystic fibrosis (CF) and
GLPG1972 in osteoarthritis well-tolerated and no emerging safety
signals observed in healthy volunteers
The post BRIEF-Galapagos gives R&D update appeared first on NASDAQ.
Forex – financial instrument.Forex news
* C1 corrector GLPG2222 for cystic fibrosis (CF) and
GLPG1972 in osteoarthritis well-tolerated and no emerging safety
signals observed in healthy volunteers
The post BRIEF-Galapagos gives R&D update appeared first on NASDAQ.